Pool Global Partners
VC Fund
Toronto, Canada
Pool Global Partners is a VC fund in Toronto focused on Health Care and Software. New emerging manager for deep technology and digital health
- Total investments:
- 11
- Last investment:
- Lead investor:
- 9%
Last updated:
For AI agents: llms.txt
Industries Pool Global Partners invests in
Stages Pool Global Partners invests in
Countries Pool Global Partners invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $900k–$5M
Investment Focus
Industry
- Health Care 6 (55%)
- Software 3 (27%)
- Artificial Intelligence 3 (27%)
- Mobile 2 (18%)
- Medical 2 (18%)
Stage
- Seed 7 (64%)
- Pre-Seed 1 (9%)
- Series A 1 (9%)
- Venture - Series Unknown 1 (9%)
Country
- Canada 7 (64%)
- United States 2 (18%)
- Denmark 1 (9%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Sally Daub
Founder and Managing Partner
|
Founder and Managing Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Oncoustics is creating and deploying advanced AI solutions for low cost, non-invasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical need. Unlike other players in the space, Oncoustics does not do image recognition. Instead, Oncoustics applies AI to raw ultrasound signals from readily available handheldultrasound devices to rapidly differentiate healthy versus diseased tissues. There's a wealth of information in these raw signals and this approach reveals novel biomarkers that can be aligned with existing standards and categorization systems. Initially targeting liver disease, a $30B global diagnostic market, Oncoustics has filed a Breakthrough Device Designation Request with the FDA for the OnX that detects liver fibrosis and the 510K is underway. Several follow-on liver products are in development. Oncoustics also has clinical data on other organ indications including prostate, kidney, breast and thyroid diseases and cancers. | $5M / Seed / Jul 21, 2022 | ||
| Modl.ai delivers game technology that accelerates game development and enhances player engagement around the world. | $1.7M / Seed / Feb 03, 2020 | ||
| Prescryptive Health is a digital health company focused on improving the prescription drug market | Seed / Apr 01, 2019 | ||
| Acorn Biolabs is a healthcare technology company that provides access to the future of cell-based medicine through a non-invasive, follicle-based cell collection and cryopreservation service. Acorn Biolabs is cryopreserving people's healthy young cells for use in future regenerative treatments. Acorn Biolabs' services are available toconsumers directly through at-home and in-clinic collections and are available across Canada through a network of clinic and pharmacy partners. | $2.5M / Seed / Jan 11, 2019 | ||
| Rentlogic is a tech-enabled standards organization that grades every apartment building in New York City (A, B, C, and F) for health and safety. The grades are based on physical inspections and public data from city agencies. Rentlogic’s methodology was developed in collaboration with stakeholders from all facets of the housing sector to be fair,credible and objective. | $2.4M / Seed / May 15, 2018 | ||
| Tread is a platform for managing construction equipment services. Tread allows contractors, brokers, and operators to interact as if they’re in the same fleet. | Pre-Seed / Jan 13, 2018 | ||
| MIMOSA Diagnostics is the maker of the MIMOSA Pro, a handheld device that uses near-infrared light to accurately and non-invasively assess tissue health. It can be easily used by a patient or a caregiver, and the images produced will help inform the next steps within patient navigation and management | $1.3M / Seed / Jul 10, 2017 | ||
| Plantiga provides human movement intelligence, a deep insight into health based on the way people move. Its platform is built to optimize health, prevent injury, and monitor recovery by detecting changes in functional movement patterns that the eye cannot see. The company was founded in 2017 and is headquartered in Vancouver, British Columbia. | Venture - Series Unknown / May 17, 2017 | ||
| InnerSpace is a space utilization platform that helps large enterprises make smarter decisions about using corporate real estate. Our powerful technology leverages a company's existing Wi-Fi infrastructure to provide unrivaled, multi-dimensional data without all the cost and effort needed for traditional sensor-based systems. | $900K / Seed / Feb 15, 2017 | ||
| Oncoustics is creating and deploying advanced AI solutions for low cost, non-invasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical need. Unlike other players in the space, Oncoustics does not do image recognition. Instead, Oncoustics applies AI to raw ultrasound signals from readily available handheldultrasound devices to rapidly differentiate healthy versus diseased tissues. There's a wealth of information in these raw signals and this approach reveals novel biomarkers that can be aligned with existing standards and categorization systems. Initially targeting liver disease, a $30B global diagnostic market, Oncoustics has filed a Breakthrough Device Designation Request with the FDA for the OnX that detects liver fibrosis and the 510K is underway. Several follow-on liver products are in development. Oncoustics also has clinical data on other organ indications including prostate, kidney, breast and thyroid diseases and cancers. | Seed / Sep 08, 2014 | ||
| See all 11 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Pool Global Partners invest in?
Pool Global Partners invests primarily in Health Care, Software and Artificial Intelligence startups, most often at Seed and Pre-Seed stage. Most of the 11 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Pool Global Partners's check size?
Pool Global Partners typically joins rounds of $900k–$5M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Pool Global Partners participates in.
How do I contact Pool Global Partners?
Public channels for Pool Global Partners include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Pool Global Partners?
The team at Pool Global Partners includes Sally Daub (Founder and Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
